DISCOVER YOUR NEXT BREAKTHROUGH
Deep Expertise. Customized Solutions.
Discover the next generation of breakthrough CNS therapies with an experienced preclinical CRO. With superior science, creativity, and the know-how to identify promise, PsychoGenics’ leading scientists are adept at illuminating your program’s best candidate.
We apply decades of early-stage drug development experience and a fully customized approach to hone in on the right therapy for your indication of interest. With industry-leading disease models and advanced analytics, we quantify your product’s potential and highlight your best path forward.
New Year, New Breakthroughs: Unlock Free Studies Worth Up to $80K! Learn more!
The Proven Power of Experience
Combine our expertise with yours to discover your next breakthrough.
20+
years of experience
400+
client relationships with >70% of clients returning
20%+
team members with a Ph.D.
30+
disease models
50+
behavioral assays
Key Therapeutic Areas
PsychoGenics has extensive experience in a broad range of early-stage drug discovery areas. Our preclinical testing services and industry-leading models cover a broad range of therapeutic areas, enabling a customized approach that fits your specific needs across the therapeutic spectrum.
Our Technologies and Capabilities
PsychoGenics conducts pioneering early preclinical research, with unsurpassed services ranging from sectioning to microdialysis to EEG. With our proprietary suite of automated Cube platforms, we combine machine learning, computer vision, and proprietary bioinformatics to spark the phenotypic discovery of your breakthrough. From the many to the few, we help you spotlight the right compound and highlight your best path for advancement at PsychoGenics.
Science and technology are tightly intertwined, and we use sophisticated tools and methodologies that deliver the industry’s highest quality data.
Our comprehensive preclinical drug development capabilities: